Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide 2.4mg and above) is available in the UK through two routes: the NHS and private prescription services registered with the GPhC. It is a prescription-only medicine, so a prescriber must assess your suitability before any supply can happen. Understanding which route actually fits your situation is the real decision here. Learn more about Wegovy and how it works before exploring how to access it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE recommends semaglutide for weight management (TA875) for adults with a BMI of 35 or above and at least one weight-related health condition, used for a maximum of two years within a specialist multidisciplinary weight management service. Thresholds are typically 2.5 kg/m² lower for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. You can read the exact criteria in NICE's appraisal of semaglutide (TA875).
In practice, accessing Wegovy on the NHS means a GP referral to a specialist weight management service, followed by a structured programme alongside the medicine. That wraparound care is genuinely useful, but the waiting lists for these services are commonly long, and not every area has the same capacity. If you meet the criteria, it is worth asking your GP. If you do not meet the NHS threshold, or you would prefer not to wait, a private prescription is the other lawful option.
Scotland, Wales and Northern Ireland each commission weight management services slightly differently, so availability and criteria can vary. The NHS pathway is worth exploring regardless of where you live, but it helps to go in with realistic expectations about timelines.
A private prescription for Wegovy follows the same legal framework as an NHS one. A prescriber (a doctor, nurse prescriber, or pharmacist independent prescriber) must assess you, confirm eligibility against the licensed criteria, and issue a prescription before any medicine is dispensed. The difference is speed and access: no referral, no waiting list, and the assessment can happen online.
The safest way to check any online pharmacy before you share personal or medical information is to spend thirty seconds on the GPhC's online pharmacy register. Search by name or web address. If it is not listed, do not proceed. A legitimate service will also carry out identity verification and confirm your current weight, some do this by video. nume uses live weight verification and photo-ID checks as standard, and every consultation is read by a GPhC-registered Independent Prescriber. Once clinically approved, treatment is dispatched the same day for free next-working-day tracked delivery.
For a sense of what private treatment costs and what a transparent price should include, the Wegovy price guide covers the market honestly.
The MHRA has issued repeated warnings about fake weight-loss pens sold through social media, unofficial websites, and unverified online sellers. Around 20 million doses of illegally traded weight-loss medicines, worth roughly £45 million, were seized in 2025 alone, and the first UK site producing counterfeit tirzepatide pens was raided that same year. Counterfeit pens have been found to contain insulin rather than the stated medicine, with serious consequences for some people who received them. The MHRA's Yellow Card scheme accepts reports of both suspected side effects and suspect sellers.
Red flags to watch for: a seller offering Wegovy without any clinical assessment; prices far below what any legitimate pharmacy charges; discount codes or vouchers attached to a prescription medicine. These are not bargains, they are markers of an unregulated supply chain. The confusion between Wegovy and Ozempic is also worth understanding, since counterfeit products are sometimes mislabelled or conflated.
The decision comes down to three practical questions. Do you meet the NHS criteria? Are you willing to wait? And does a specialist weight management service fit your life right now? If the answer to any of those is uncertain, a private prescription through a regulated pharmacy is a well-established, legal alternative.
Wegovy is now available at higher doses too. The MHRA approved a dedicated single-dose 7.2mg pen in April 2026, and trials reported around 20.7% average weight loss at that dose over 72 weeks, narrowing the gap with tirzepatide. Whether that dose is appropriate for you is a conversation for a prescriber, not a product page.
If you are ready to find out whether you are clinically suitable, the free consultation at nume is reviewed the same day by a real prescriber. There is no obligation, no subscription, and no referral needed. Practical guidance on where to inject Wegovy, including the specific sites on your body where you can jab Wegovy and how to store your pens correctly is also available once you are ready to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.